$TRNO
Terreno Realty Corp Stock $trno

$trno Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000147615024000008 Filed on May 08, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$94.25M	$85.03M
YoY Change	18.5%	13.9%
Cost Of Revenue	$23.77M	$20.89M
YoY Change	27.9%	13.65%
Gross Profit	$70.48M	$64.14M
YoY Change	15.63%	13.99%
Gross Profit Margin	74.78%	75.43%
Selling, General & Admin	$10.54M	$10.51M
YoY Change	7.96%	12.77%
% of Gross Profit	14.96%	16.39%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$23.01M	$20.94M
YoY Change	26.22%	15.31%
% of Gross Profit	32.65%	32.65%
Operating Expenses	$33.56M	$31.45M
YoY Change	19.85%	14.45%
Operating Profit	$36.92M	$32.69M
YoY Change	12.05%	13.55%
Interest Expense	-$1.188M	$5.240M
YoY Change	-75.89%	-28.95%
% of Operating Profit	-3.22%	16.03%
Other Income/Expense, Net	-$1.188M	$3.368M
YoY Change	-116.21%	-162.23%
Pretax Income	$35.70M	$36.06M
YoY Change	-11.32%	54.55%
Income Tax
% Of Pretax Income
Net Earnings	$35.70M	$36.06M
YoY Change	-10.92%	54.55%
Net Earnings / Revenue	37.87%	42.41%
Basic Earnings Per Share	$0.37	$0.40
Diluted Earnings Per Share	$0.37	$0.40
COMMON SHARES
Basic Shares Outstanding	96.70M shares	88.00M shares
Diluted Shares Outstanding	96.41M shares	89.44M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$182.0M	$649.6M
YoY Change	208.87%	5776.38%
Cash & Equivalents	$182.0M	$649.6M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$182.0M	$649.6M
YoY Change	208.87%	5776.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.202B	$3.699B
YoY Change	19.85%	6.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$461.0K	$10.87M
YoY Change	-58.13%	-27.1%
Total Long-Term Assets	$4.285B	$3.789B
YoY Change	19.74%	6.22%
TOTAL ASSETS
Total Short-Term Assets	$182.0M	$649.6M
Total Long-Term Assets	$4.285B	$3.789B
Total Assets	$4.467B	$4.439B
YoY Change	22.8%	24.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$77.86M	$63.85M
YoY Change	23.02%	22.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$158.2M	$141.1M
YoY Change	22.62%	22.68%
LONG-TERM LIABILITIES
Long-Term Debt	$772.0M	$771.8M
YoY Change	0.11%	0.11%
Other Long-Term Liabilities	$95.99M	$81.34M
YoY Change	7.81%	-12.1%
Total Long-Term Liabilities	$868.0M	$853.1M
YoY Change	0.9%	-1.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$158.2M	$141.1M
Total Long-Term Liabilities	$868.0M	$853.1M
Total Liabilities	$1.026B	$994.2M
YoY Change	3.74%	1.61%
SHAREHOLDERS EQUITY
Retained Earnings	$80.29M	$88.12M
YoY Change	-5.75%	12.41%
Common Stock	$3.392B	$3.388B
YoY Change	30.71%	32.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.441B	$3.445B
YoY Change
Total Liabilities & Shareholders Equity	$4.467B	$4.439B
YoY Change	22.8%	24.05%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$35.70M	$36.06M
YoY Change	-10.92%	54.55%
Depreciation, Depletion And Amortization	$23.01M	$20.94M
YoY Change	26.22%	15.31%
Cash From Operating Activities	$64.33M	$47.04M
YoY Change	32.47%	21.23%
INVESTING ACTIVITIES
Capital Expenditures	$48.26M	$40.10M
YoY Change	59.72%	76.13%
Acquisitions
YoY Change
Other Investing Activities	-$450.3M	-$8.485M
YoY Change	-4159.48%	-97.67%
Cash From Investing Activities	-$498.5M	-$48.58M
YoY Change	2506.74%	-87.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-43.79M	$495.8M
YoY Change	-358.73%	48.37%
NET CHANGE
Cash From Operating Activities	64.33M	$47.04M
Cash From Investing Activities	-498.5M	-$48.58M
Cash From Financing Activities	-43.79M	$495.8M
Net Change In Cash	-478.0M	$494.2M
YoY Change	-1131.01%	-3526.32%
FREE CASH FLOW
Cash From Operating Activities	$64.33M	$47.04M
Capital Expenditures	$48.26M	$40.10M
Free Cash Flow	$16.07M	$6.941M
YoY Change	-12.41%	-56.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	87487098	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	87487098	shares
CY2024Q1	us-gaap	Revenues Revenues	85030000	usd
CY2023Q1	us-gaap	Revenues Revenues	74651000	usd
CY2024Q1	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	20890000	usd
CY2023Q1	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	18381000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20939000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18159000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10510000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9320000	usd
CY2024Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	48000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	52339000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	45908000	usd
CY2024Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	2893000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1963000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	5240000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7375000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	5715000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3368000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5412000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	36059000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23331000	usd
CY2024Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	154000	usd
CY2023Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	105000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	35905000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35905000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	23226000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	23226000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.29
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	88873871	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79895886	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89436149	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	80344742	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2914627000	usd
CY2024Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3226000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	535042000	usd
CY2024Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	983000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3356000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	43517000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	3444584000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2229851000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23331000	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	943000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	377488000	usd
CY2023Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	627000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3038000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	33209000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2599872000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	36059000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23331000	usd
CY2024Q1	us-gaap	Straight Line Rent StraightLineRent	1451000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	2173000	usd
CY2024Q1	trno	Amortization Of Lease Intangibles AmortizationOfLeaseIntangibles	3350000	usd
CY2023Q1	trno	Amortization Of Lease Intangibles AmortizationOfLeaseIntangibles	3541000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20939000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18159000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	5715000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	387000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	383000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3356000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3038000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3763000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3998000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	577000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3602000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47039000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	38801000	usd
CY2024Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	18657000	usd
CY2023Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	364600000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	10172000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2024Q1	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	32216000	usd
CY2023Q1	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	8904000	usd
CY2024Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	7882000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	13862000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48583000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-387366000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	538269000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	366499000	usd
CY2024Q1	trno	Issuance Costs On Issuance Of Common Stock IssuanceCostsOnIssuanceOfCommonStock	2477000	usd
CY2023Q1	trno	Issuance Costs On Issuance Of Common Stock IssuanceCostsOnIssuanceOfCommonStock	978000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	983000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	627000	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	29000000	usd
CY2024Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	29000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	39052000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	30753000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	495757000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	334141000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	494213000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14424000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166236000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28083000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	660449000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13659000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	9750000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	8381000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	29062000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	17219000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	5547000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1228000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	trno	Reconciliation Acquisition Of Properties ReconciliationAcquisitionOfProperties	18628000	usd
CY2023Q1	trno	Reconciliation Acquisition Of Properties ReconciliationAcquisitionOfProperties	406730000	usd
CY2024Q1	trno	Assumptions Of Other Assets And Liabilities AssumptionsOfOtherAssetsAndLiabilities	-29000	usd
CY2023Q1	trno	Assumptions Of Other Assets And Liabilities AssumptionsOfOtherAssetsAndLiabilities	42130000	usd
CY2024Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	18657000	usd
CY2023Q1	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	364600000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	6	segment
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.</span></div>
CY2024Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2024Q1	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	3400000	usd
CY2023Q1	us-gaap	Amortization Of Above And Below Market Leases AmortizationOfAboveAndBelowMarketLeases	3500000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P6Y3M18D
CY2024Q1	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	136946000	usd
CY2024Q1	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	55608000	usd
CY2024Q1	us-gaap	Below Market Lease Net BelowMarketLeaseNet	81338000	usd
CY2023Q4	us-gaap	Below Market Lease Gross BelowMarketLeaseGross	137047000	usd
CY2023Q4	us-gaap	Below Market Lease Accumulated Amortization BelowMarketLeaseAccumulatedAmortization	52329000	usd
CY2023Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	84718000	usd
CY2024Q1	trno	Finite Lived Intangible Assets Liabilities Gross FiniteLivedIntangibleAssetsLiabilitiesGross	9988000	usd
CY2024Q1	trno	Finite Lived Intangible Assets Liabilities Accumulated Amortization FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization	45037000	usd
CY2024Q1	trno	Finite Lived Intangible Assets Liabilities Net FiniteLivedIntangibleAssetsLiabilitiesNet	-35049000	usd
CY2023Q4	trno	Finite Lived Intangible Assets Liabilities Gross FiniteLivedIntangibleAssetsLiabilitiesGross	10282000	usd
CY2023Q4	trno	Finite Lived Intangible Assets Liabilities Accumulated Amortization FiniteLivedIntangibleAssetsLiabilitiesAccumulatedAmortization	44610000	usd
CY2023Q4	trno	Finite Lived Intangible Assets Liabilities Net FiniteLivedIntangibleAssetsLiabilitiesNet	-34328000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26393000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	836000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1690000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166236000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28083000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	649575000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11054000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	10874000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2605000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	660449000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13659000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	494213000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14424000	usd
CY2024Q1	trno	Straight Line Rent And Accounts Receivables Net Of Allowances StraightLineRentAndAccountsReceivablesNetOfAllowances	56600000	usd
CY2023Q4	trno	Straight Line Rent And Accounts Receivables Net Of Allowances StraightLineRentAndAccountsReceivablesNetOfAllowances	56100000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1500000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	usd
CY2024Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3100000	usd
CY2024Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	13900000	usd
CY2023Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	13500000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	usd
CY2024Q1	trno	Share Based Compensation Performance Measurement Period ShareBasedCompensationPerformanceMeasurementPeriod	P3Y
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	775000000	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3230000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	3437000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	771770000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	771563000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	100000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	50000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	150000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	200000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	275000000	usd
CY2024Q1	trno	Long Term Debt Before Net Debt Issuance Costs LongTermDebtBeforeNetDebtIssuanceCosts	775000000	usd
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3230000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	771770000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.040
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	191714000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	248407000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	215793000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	166429000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	123768000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	299079000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1245190000	usd
CY2024Q1	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	714028000	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	771770000	usd
CY2023Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	721269000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	771563000	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	trno	Sales Of Stock Weighted Average Offering Price SalesOfStockWeightedAverageOfferingPrice	64.00
CY2024Q1	trno	Fees And Commissions At Market Equity Offering Program Sales Agent FeesAndCommissionsAtMarketEquityOfferingProgramSalesAgent	2200000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	350000	shares
CY2023Q1	trno	Sales Of Stock Weighted Average Offering Price SalesOfStockWeightedAverageOfferingPrice	63.30
CY2024Q1	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	3000000	shares
CY2024Q1	trno	Stock Withdrawn During Period From Deferred Compensation Plan StockWithdrawnDuringPeriodFromDeferredCompensationPlan	0	shares
CY2023Q1	trno	Stock Withdrawn During Period From Deferred Compensation Plan StockWithdrawnDuringPeriodFromDeferredCompensationPlan	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	422563	shares
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2024Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	429583	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	373985	shares
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001476150-24-000008-index-headers.html	Edgar Link	pending
0001476150-24-000008-index.html	Edgar Link	pending
0001476150-24-000008.txt	Edgar Link	pending
0001476150-24-000008-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trno-20240331.htm	Edgar Link	pending
trno-20240331.xsd	Edgar Link	pending
trnoq12024ex-311.htm	Edgar Link	pending
trnoq12024ex-312.htm	Edgar Link	pending
trnoq12024ex-313.htm	Edgar Link	pending
trnoq12024ex-321.htm	Edgar Link	pending
trnoq12024ex-322.htm	Edgar Link	pending
trnoq12024ex-323.htm	Edgar Link	pending
trno-20240331_def.xml	Edgar Link	unprocessable
trno-20240331_lab.xml	Edgar Link	unprocessable
trno-20240331_pre.xml	Edgar Link	unprocessable
trno-20240331_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
trno-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRNO
Terreno Realty Corp Stock $trno

2024 Q2 Form 10-Q Financial Statement

#000147615024000008 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNO Terreno Realty Corp Stock $trno

2024 Q2 Form 10-Q Financial Statement

#000147615024000008 Filed on May 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNO
Terreno Realty Corp Stock $trno